PainChek Future Growth

Future criteria checks 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für PainChek zu prognostizieren.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare Services earnings growth26.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

May 07
When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Nov 20
Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Recent updates

We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate

Jul 04
We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate

Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?

Feb 08
Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?

Will PainChek (ASX:PCK) Spend Its Cash Wisely?

Jul 05
Will PainChek (ASX:PCK) Spend Its Cash Wisely?

Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth

Jan 26
Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth

We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow

Sep 07
We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

May 07
When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business

Mar 01
PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Nov 20
Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PainChek has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:PCK - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20232-8-6-6N/A
9/30/20232-8-6-6N/A
6/30/20232-8-6-6N/A
3/31/20232-7-6-6N/A
12/31/20221-7-6-6N/A
9/30/20221-6-6-6N/A
6/30/20221-6-7-7N/A
3/31/20221-6-7-7N/A
12/31/20210-7-6-6N/A
9/30/20210-6-5-5N/A
6/30/20210-6-4-4N/A
3/31/20210-5-4-3N/A
12/31/20200-4-3-3N/A
9/30/20200-8-2-2N/A
6/30/20200-12-2-2N/A
3/31/20200-12-3-3N/A
12/31/20190-12-4-4N/A
9/30/20190-8-4-4N/A
6/30/20190-3-3-3N/A
3/31/20190-3-3-3N/A
12/31/20180-3-3-3N/A
9/30/20180-4-3-3N/A
6/30/20180-5-3-3N/A
3/31/20180-5-3-3N/A
12/31/20170-5-3-3N/A
9/30/20170-7N/A-2N/A
6/30/20170-8N/A-2N/A
6/30/201600N/A0N/A

Analyst Future Growth Forecasts

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von PCK über der Sparquote liegt (2.1%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von PCK schneller wachsen werden als der Markt Australian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von PCK in den nächsten 3 Jahren signifikant steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von PCK schneller wachsen werden als der Markt von Australian.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von PCK schneller wachsen werden als 20% pro Jahr.


Earnings per Share Growth Forecasts


Future Return on Equity

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von PCK in 3 Jahren voraussichtlich hoch sein wird


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.